Shares of Moderna rose by a staggering 26.61% in 30 days from $193.24 to $166.63 at 12:15 EST on Wednesday, after two consecutive sessions in a row of losses. NASDAQ Composite is rising 0.75% to $13,889.75, after two sequential sessions in a row of losses. This seems, up until now, a somewhat positive trend trading session today.
Moderna’s last close was $156.78, 13.58% under its 52-week high of $189.26.
Moderna’s sales growth is 24436.2% for the present quarter and 6199.3% for the next. The company’s growth estimates for the current quarter and the next is 888.6% and 1938.7%, respectively.
Year-on-year quarterly revenue growth grew by 3960.8%, now sitting on 803.4M for the twelve trailing months.
Moderna’s Stock Yearly Top and Bottom Value
Moderna’s stock is valued at $166.63 at 12:15 EST, way below its 52-week high of $189.26 and way above its 52-week low of $30.98.
Moderna’s Moving Average
Moderna’s worth is way above its 50-day moving average of $143.54 and way above its 200-day moving average of $119.02.
More news about Moderna.